Dentzer James E 4

What Happened

• James E. Dentzer, President, CEO and Director of Curis, received an equity award (derivative grant) for 110,090 shares at an exercise/strike price of $5.29 per share, representing a notional value of $582,376. The Form 4 reports this as a grant (transaction code A), not an open-market purchase or sale.

Key Details

• Transaction date: July 7, 2026. Filing date: July 9, 2026 (timely; Form 4 due within two business days).
• Grant details: 110,090 shares; price $5.29 per share; aggregate $582,376 (derivative award/option grant).
• Shares owned after transaction: Not specified in the provided filing summary.
• Footnote: Vesting schedule — 25% of the original shares vest on July 7, 2027, then an additional 6.25% of the original shares vest each successive quarter through July 7, 2030 (see footnote F1).
• Exhibit: Power of Attorney (Exhibit 24.1) included.

Context

• This filing documents an option/award grant (derivative compensation). It is not an exercise or a sale, so no immediate cash proceeds or open-market buying/selling occurred. The grant vests over time per the schedule above and is a typical form of executive compensation rather than a direct market signal.